Brief: Cannaroyalty And Aequus Pharmaceuticals Announce JV To Develop And Commercialize Cannabis-Based Therapies Targeting Neurological Disorders
11/01/2018 11:03
Jan 11 (Reuters) - Aequus Pharmaceuticals Inc AQS.V :
* CANNAROYALTY AND AEQUUS PHARMACEUTICALS ANNOUNCE JOINT
VENTURE
TO DEVELOP AND COMMERCIALIZE CANNABIS-BASED THERAPIES TARGETING
NEUROLOGICAL DISORDERS
Source text for Eikon: ID:nPn56kfwza
Further company coverage: AQS.V
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Aequus Pharmaceuticals
See all newsBrief: Aequus Pharmaceutical Canada Pauses Sales Of Evolve Intensive Eyedrops, Gel In Canada
Brief: Aequus Announces Financing To Support Launch Of Zimed Preservative Free (Bimatoprost 0.03%) And Board Update
Brief: Aequus Announces Health Canada Notice Of Compliance For Zimed® Preservative Free
Brief: Aequus Announces Sandoz Contract Expiry At Year End And Expected Health Canada Approval For Zimed® Pf (Preservative Free)
Brief: Aequus Resumes Trading On TSX Venture Exchange